Stock Rich List
Nasdaq: ARQT

Arcutis Biotherapeutics insiders

The officers, directors and 10% owners of Arcutis Biotherapeutics, Inc. who hold the most stock, valued at the live ARQT price.

$27.17
ARQT today −$440K (−1.59%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
9
Their ARQT stock
$546M
Market value
$3.44B
Held by ranked insiders
15.9%

Insiders by value of ARQT holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Frazier Life Sciences VIII, L.P.10% owner8,827,254$240M6.98%Corporate
2Fhm Life Sciences Viii, L.P.10% owner8,738,567$237M6.91%Corporate
3Bhaskar ChaudhuriDirector917,807$24.9M0.73%4263rd
4Todd WatanabeSee Remarks776,318$21.1M0.61%4983rd
5David W. OsborneChief Technical Officer268,854$7.3M0.21%11069th
6Christopher PeetzDirector191,815$5.2M0.15%2840th
7Larry Todd EdwardsSee Remarks175,178$4.8M0.14%6613th
8John W. SmitherChief Financial Officer152,757$4.2M0.12%12738th
9Scott L. BurrowsChief Financial Officer59,115$1.6M<0.1%9209th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Arcutis Biotherapeutics; see each profile for the filing.